You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (8)

Journals (0)

1-8 of 8 results for CD52 antigen

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: A New Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) for Alemtuzumab Determination: Development,Validation and Application

Free access

Research article

First published 2007-4

A New Sensitive Enzyme-Linked Immunosorbent Assay (ELISA) for Alemtuzumab Determination: Development,Validation and Application

M. Montagna, M.A. Avanzini, L. Visai [...]

International Journal of Immunopathology and Pharmacology

Select article: Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis

Retricted access

Research article

First published 2017-9

Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis

Rafael Arroyo González, Mariko Kita, Heidi Crayton [...]

Multiple Sclerosis Journal

Select article: Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use

Free access

Review article

First published 2012-12

Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use

Jeremy L. Warner, Jon E. Arnason

Therapeutic Advances in Hematology

Select article: Alemtuzumab (Campath-1H,Campath1) for the treatment of lymphoid malignancies: chronic lymphocytic leukemia and T-cell prolymphocytic leukemia

Retricted access

Research article

First published 2001-12

Alemtuzumab (Campath-1H,Campath1) for the treatment of lymphoid malignancies: chronic lymphocytic leukemia and T-cell prolymphocytic leukemia

Helen T Wu

Journal of Oncology Pharmacy Practice

Select article: Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapy

Retricted access

Research article

First published 1998-06

Disease activity and the immune set in multiple sclerosis: blood markers for immunotherapy

A J Coles, M G Wing, D AS Compston

Multiple Sclerosis Journal

Select article: Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

Free access

Review article

First published 2015-1

Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

Eva Havrdova, Dana Horakova, Ivana Kovarova

Therapeutic Advances in Neurological Disorders

Select article: CAMPATH-1H in multiple sclerosis

Retricted access

Research article

First published 1996-06

CAMPATH-1H in multiple sclerosis

Th Moreau, A Coles, M Wing [...]

Multiple Sclerosis Journal

Select article: Future perspectives in target-specific immunotherapies of myasthenia gravis

Free access

Review article

First published 2015-11

Future perspectives in target-specific immunotherapies of myasthenia gravis

Marinos C. Dalakas

Therapeutic Advances in Neurological Disorders

1
10 / page

Article type

Publication date

Subjects

Access